Atai Life Sciences Investor Relations Material
Latest events
Study Update
Atai Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Atai Life Sciences N.V.
Access all reports
Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company focusing on the acquisition, incubation, and development of therapeutics aimed at treating a range of mental health disorders such as depression, anxiety, addiction, among others. The company is developing a decentralized platform approach to expedite the development of effective mental health treatments. The company is headquartered in Berlin, Germany, and its shares are listed on the NASDAQ.
Key slides for Atai Life Sciences N.V.
M&A Announcement
Atai Life Sciences N.V.
Corporate Presentation
Atai Life Sciences N.V.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ATAI
Country
🇺🇸 United States